PRKAA1 Produkte
(Protein Kinase, AMP-Activated, alpha 1 Catalytic Subunit (PRKAA1))
Kategorien
The protein encoded by this gene belongs to the ser/thr protein kinase family. It is the catalytic subunit of the 5'-prime-AMP-activated protein kinase (AMPK). AMPK is a cellular energy sensor conserved in all eukaryotic cells. The kinase activity of AMPK is activated by the stimuli that increase the cellular AMP/ATP ratio. AMPK regulates the activities of a number of key metabolic enzymes through phosphorylation. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. Alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte PRKAA1 Kategorien
PRKAA1 Antikörper
High quality antibodies with extensive validation data.
PRKAA1 ELISA Kits
Reliable ELISA kits for a wide range of species.
PRKAA1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene PRKAA1 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IF
Validierungen
- (3)
- (13)
Kat. Nr.
ABIN3021788
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IHC, IP, ICC
Validierungen
- (7)
Kat. Nr.
ABIN7440413
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
WB, IHC
Validierungen
- (7)
Kat. Nr.
ABIN7265094
Menge
200 μL
Datenblatt
Datenblatt
Empfohlene PRKAA1 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human, Mouse, Rat
Analytical Method
Semi-Quantitative Sandwich ELISA
Validierungen
- (3)
Kat. Nr.
ABIN5526721
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Analytical Method
Semi-Quantitative Sandwich ELISA
Validierungen
- (3)
Kat. Nr.
ABIN5526722
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Competition ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6969725
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene PRKAA1 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN7124656
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1316204
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1316206
Menge
10 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren PRKAA1 Produkten
: "Fatty Acids Regulate Porcine Reproductive and Respiratory Syndrome Virus Infection via the AMPK-ACC1 Signaling Pathway." in: Viruses, Vol. 11, Issue 12, (2020) (PubMed).: "Reduced AMPK activation and increased HCAR activation drive anti-inflammatory response and neuroprotection in glaucoma." in: Journal of neuroinflammation, Vol. 15, Issue 1, pp. 313, (2019) (PubMed).
: "STIM2 interacts with AMPK and regulates calcium-induced AMPK activation." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Issue 2, pp. 2957-2970, (2019) (PubMed).
: "High CO2 downregulates skeletal muscle protein anabolism via AMPKα2-mediated depressed ribosomal biogenesis." in: American journal of respiratory cell and molecular biology, (2019) (PubMed).
: "A muscle-specific UBE2O/AMPKα2 axis promotes insulin resistance and metabolic syndrome in obesity." in: JCI insight, Vol. 4, Issue 13, (2019) (PubMed).
: "Protective effects of melatonin against nicotine-induced disorder of mouse early folliculogenesis." in: Aging, Vol. 10, Issue 3, pp. 463-480, (2019) (PubMed).
: "Decrease in male mouse fertility by hydrogen sulfide and/or ammonia can Be inheritable." in: Chemosphere, Vol. 194, pp. 147-157, (2018) (PubMed).
: "Antidiabetic activities of entagenic acid in type 2 diabetic db/db mice and L6 myotubes via AMPK/GLUT4 pathway." in: Journal of ethnopharmacology, Vol. 211, pp. 366-374, (2018) (PubMed).
: "CO suppresses prostate cancer cell growth by directly targeting LKB1/AMPK/mTOR pathway in vitro and in vivo." in: Urologic oncology, Vol. 36, Issue 6, pp. 312.e1-312.e8, (2018) (PubMed).
: "Alternative polyadenylation drives genome-to-phenome information detours in the AMPKα1 and AMPKα2 knockout mice." in: Scientific reports, Vol. 8, Issue 1, pp. 6462, (2018) (PubMed).
Synonyme und alternative Namen zu PRKAA1
protein kinase AMP-activated catalytic subunit alpha 1 (PRKAA1), protein kinase, AMP-activated, alpha 1 catalytic subunit (prkaa1), protein kinase, AMP-activated, alpha 1 catalytic subunit (PRKAA1), protein kinase AMP-activated catalytic subunit alpha 1 (Prkaa1), protein kinase, AMP-activated, alpha 1 catalytic subunit (Prkaa1), protein kinase, AMP-activated, alpha 1 catalytic subunit L homeolog (prkaa1.L), AI194361, AI450832, AL024255, AMPK, ampk, AMPK1, AMPKa1, ampka1, AMPKalpha1, C130083N04Rik, cb116, im:7154392, PRKAA1, sb:cb130, wu:fa94c10Bezeichner auf Proteinebene für PRKAA1
- 5'-AMP-activated protein kinase catalytic subunit alpha-1
- 5'-AMP-activated protein kinase, catalytic alpha-1 chain
- ACACA kinase
- AMP -activate kinase alpha 1 subunit
- AMP-activated protein kinase, catalytic, alpha-1
- AMPK alpha 1
- AMPK subunit alpha-1
- HMGCR kinase
- acetyl-CoA carboxylase kinase
- hydroxymethylglutaryl-CoA reductase kinase
- tau-protein kinase PRKAA1
- 5'-AMP-activated protein kinase alpha-1 catalytic subunit
- AMPKalpha1
- ampka1
- 5'-AMP-activated protein kinase alpha 1 catalytic subunit
- 63 kDa subunit
- AMPK 63 kDa subunit
- AMPK alpha-1 chain
- AMP-activated protein kinase, alpha 1 catalytic subunit
- 5'-AMP-activated protein kinase catalyti subunit alpha-1-like protein
- AMPK-activated protein kinase alpha-1 subunit
- protein kinase, AMP-activated, alpha 1 catalytic subunit
Haben Sie etwas anderes gesucht?
Sie sind hier:
